J Milner

2.0k total citations
23 papers, 1.6k citations indexed

About

J Milner is a scholar working on Oncology, Molecular Biology and Genetics. According to data from OpenAlex, J Milner has authored 23 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 9 papers in Molecular Biology and 5 papers in Genetics. Recurrent topics in J Milner's work include Cancer-related Molecular Pathways (13 papers), Cancer Research and Treatments (3 papers) and Epigenetics and DNA Methylation (3 papers). J Milner is often cited by papers focused on Cancer-related Molecular Pathways (13 papers), Cancer Research and Treatments (3 papers) and Epigenetics and DNA Methylation (3 papers). J Milner collaborates with scholars based in United Kingdom, Israel and Germany. J Milner's co-authors include Pierre Hainaut, Elizabeth Medcalf, A Cook, Michael J. R. Stark, Nicola J. Rolley, François Fuks, Tony Kouzarides, Samuel E. Butcher, Sarah J. Butcher and Ayelet Zauberman and has published in prestigious journals such as The EMBO Journal, Journal of Molecular Biology and Molecular and Cellular Biology.

In The Last Decade

J Milner

23 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J Milner United Kingdom 17 1.1k 901 298 204 155 23 1.6k
L. Jayaraman United States 7 1.1k 1.0× 833 0.9× 231 0.8× 184 0.9× 124 0.8× 7 1.5k
Dov Schwartz Israel 17 916 0.8× 769 0.9× 214 0.7× 152 0.7× 109 0.7× 22 1.3k
Qimin Zhan United States 14 1.6k 1.4× 988 1.1× 255 0.9× 440 2.2× 169 1.1× 23 2.3k
Gilberto Fronza Italy 26 1.4k 1.3× 941 1.0× 143 0.5× 596 2.9× 146 0.9× 95 2.1k
Kopnin Bp Russia 23 993 0.9× 619 0.7× 133 0.4× 311 1.5× 124 0.8× 79 1.5k
Kristie Clarkin United States 9 1.5k 1.3× 1.1k 1.2× 278 0.9× 332 1.6× 87 0.6× 12 2.1k
R Bovey Switzerland 9 966 0.8× 679 0.8× 325 1.1× 162 0.8× 192 1.2× 10 1.5k
Hideki Murasawa Japan 7 1.7k 1.5× 1.0k 1.1× 168 0.6× 307 1.5× 100 0.6× 13 2.2k
Ken Brown United Kingdom 12 1.5k 1.4× 862 1.0× 72 0.2× 493 2.4× 220 1.4× 16 2.2k
Ashley Craig United Kingdom 17 794 0.7× 477 0.5× 106 0.4× 179 0.9× 71 0.5× 23 1.2k

Countries citing papers authored by J Milner

Since Specialization
Citations

This map shows the geographic impact of J Milner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Milner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Milner more than expected).

Fields of papers citing papers by J Milner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J Milner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Milner. The network helps show where J Milner may publish in the future.

Co-authorship network of co-authors of J Milner

This figure shows the co-authorship network connecting the top 25 collaborators of J Milner. A scholar is included among the top collaborators of J Milner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Milner. J Milner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ghobara, Tarek, et al.. (2019). Five-year study assessing the clinical utility of anti-Müllerian hormone measurements in reproductive-age women with cancer. Reproductive BioMedicine Online. 39(4). 712–720. 6 indexed citations
2.
Milner, J, François Fuks, Luke Hughes‐Davies, & Tony Kouzarides. (2000). The BRCA2 activation domain associates with and is phosphorylated by a cellular protein kinase. Oncogene. 19(38). 4441–4445. 19 indexed citations
3.
Fuks, François, J Milner, & Tony Kouzarides. (1998). BRCA2 associates with acetyltransferase activity when bound to P/CAF. Oncogene. 17(19). 2531–2534. 80 indexed citations
4.
Okorokov, Andrei L. & J Milner. (1997). Proteolytic cleavage of p53: a model for the activation of p53 in response to DNA damage.. PubMed. 9(6-7). 267–73. 17 indexed citations
5.
Thompson, L D, et al.. (1997). Identification of a nonpathogenic Erwinia amylovora gua B mutant. Plant Pathology. 46(4). 594–599. 14 indexed citations
6.
Rolley, Nicola J., Samuel E. Butcher, & J Milner. (1995). Specific DNA binding by different classes of human p53 mutants.. PubMed. 11(4). 763–70. 74 indexed citations
7.
Rolley, Nicola J. & J Milner. (1994). Specific DNA binding by p53 is independent of mutation at serine 389, the casein kinase II site.. PubMed. 9(10). 3067–70. 16 indexed citations
8.
Milner, J, David Dymock, Richard M. Cooper, & Ian S. Roberts. (1993). Penicillin-binding proteins from Erwinia amylovora: mutants lacking PBP2 are avirulent. Journal of Bacteriology. 175(19). 6082–6088. 12 indexed citations
9.
Milner, J, et al.. (1993). Partially transformed T3T3 cells express high levels of mutant p53 in the 'wild-type' immunoreactive form with defective oligomerization.. PubMed. 8(7). 2001–8. 10 indexed citations
10.
Shaulian, Eitan, Ayelet Zauberman, J Milner, Erika Davies, & Moshe Oren. (1993). Tight DNA binding and oligomerization are dispensable for the ability of p53 to transactivate target genes and suppress transformation.. The EMBO Journal. 12(7). 2789–2797. 64 indexed citations
11.
Hainaut, Pierre & J Milner. (1993). Redox modulation of p53 conformation and sequence-specific DNA binding in vitro.. PubMed. 53(19). 4469–73. 353 indexed citations
12.
Medcalf, Elizabeth, Takashi Takahashi, Itsuo Chiba, John D. Minna, & J Milner. (1992). Temperature-sensitive mutants of p53 associated with human carcinoma of the lung.. PubMed. 7(1). 71–6. 28 indexed citations
14.
Zerrahn, Jens, et al.. (1992). Correlation between the conformational phenotype of p53 and its subcellular location.. PubMed. 7(7). 1371–81. 45 indexed citations
15.
Coleman, Mark, J Milner, Richard M. Cooper, & Ian S. Roberts. (1991). The use of TnphoAinErwinia amylovorato generate random fusions of alkaline phosphatase to extracytoplasmic proteins. FEMS Microbiology Letters. 80(2-3). 167–172. 5 indexed citations
16.
Milner, J, Elizabeth Medcalf, & A Cook. (1991). Tumor suppressor p53: analysis of wild-type and mutant p53 complexes.. Molecular and Cellular Biology. 11(1). 12–19. 200 indexed citations
17.
Milner, J & Elizabeth Medcalf. (1990). Temperature-dependent switching between “wild-type” and “mutant” forms of p53-Val135. Journal of Molecular Biology. 216(3). 481–484. 73 indexed citations
18.
Milner, J, et al.. (1990). Addition of fresh medium induces cell cycle and conformation changes in p53, a tumour suppressor protein.. PubMed. 5(11). 1683–90. 85 indexed citations
20.
Milner, J, et al.. (1980). Lymphocyte stimulation: concanavalin A induces the expression of a 53K protein. Cell Biology International Reports. 4(7). 663–667. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026